Description
In December 2025, the U.S. Food and Drug Administration (FDA) cleared Medtronic’s Hugo™ robotic-assisted surgery (RAS) system for use in urologic surgical procedures, bringing a versatile robotic-assisted platform to U.S. surgeons and health systems seeking to expand soft-tissue robotic surgery programs and access to minimally invasive care.
Click HERE to learn more.
Reviews
There are no reviews yet.